TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Sever Pharma Solutions AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
425,701
|
407,559
|
347,468 |
Financial expenses |
3,702
|
3,852
|
2,910 |
Earnings before taxes |
-15,819
|
11,282
|
20,332 |
EBITDA |
5,481
|
29,842
|
35,491 |
Total assets |
427,874
|
365,505
|
331,357 |
Current assets |
232,131
|
186,582
|
143,352 |
Current liabilities |
145,964
|
129,459
|
68,547 |
Equity capital |
270,121
|
220,953
|
165,500 |
- share capital |
6,717
|
6,682
|
7,271 |
Employees (average) |
322
|
312
|
278 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.1%
|
60.5%
|
49.9% |
Turnover per employee |
1,322
|
1,306
|
1,250 |
Profit as a percentage of turnover |
-3.7%
|
2.8%
|
5.9% |
Return on assets (ROA) |
-2.8%
|
4.1%
|
7.0% |
Current ratio |
159.0%
|
144.1%
|
209.1% |
Return on equity (ROE) |
-5.9%
|
5.1%
|
12.3% |
Change turnover |
16,044
|
88,236
|
27,224 |
Change turnover % |
4%
|
28%
|
9% |
Chg. No. of employees |
10
|
34
|
22 |
Chg. No. of employees % |
3%
|
12%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.